Načítá se...
The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta‐analysis
BACKGROUND: Bladder cancer is one of the most common urological cancers all over the world, and NMIBC occupies almost 80% of recently diagnosed bladder cancer cases. Progress and recurrence of bladder cancer are the main problems during the disease. The level of TP53 mutation is obviously higher in...
Uloženo v:
| Vydáno v: | J Clin Lab Anal |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8128305/ https://ncbi.nlm.nih.gov/pubmed/33780049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23765 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|